arrow_left You’re on the news side, go back to data on Merck

News on Merck

3 days ago

There has been 47 news on Merck in the past from 9 different sources and amongst 3 sections

dataset_white Full dataset

Evolution through time

Latest news

CNBC News
Merck says Keytruda injection on par with approved IV version in trial
Read link
Nov 19, 2024
CNBC News
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Read link
Nov 07, 2024
CNBC News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Read link
Oct 22, 2024
CNBC News
Stocks making the biggest premarket moves: Boeing, Dell, Merck and more
Read link
Sep 10, 2024
The Wall Street Journal
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Read link
Aug 14, 2024
The Wall Street Journal
Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion
Read link
Aug 09, 2024
CNBC News
Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda
Read link
Jul 31, 2024
CNBC News
Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more
Read link
Jul 31, 2024
The Wall Street Journal
Merck is betting on AI partnerships to develop new drugs, but refraining from bringing in external expertise through acquisitions.
Read link
Jun 08, 2024
The Wall Street Journal
Germany's Merck Bets on AI Drug-Design Pacts, Rules Out M&A
Read link
Jun 07, 2024

Distribution by section

The coverage span across 3 distinct sections:

Distribution by publisher

There has been 9 publishers reporting on this, here are the top ones:

  • CNBC News (38%)
  • The Wall Street Journal (30%)
  • Quartz (11%)
  • Financial Times (6%)
  • VentureBeat (4%)

Details

This content can be used under the CC BY 4.0 license